Literature DB >> 27297347

Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China.

Yangfeng Wu1, Emelia J Benjamin2, Stephen MacMahon2.   

Abstract

With one-fifth of the world's total population, China's prevention and control of cardiovascular disease (CVD) may affect the success of worldwide efforts to achieve sustainable CVD reduction. Understanding China's current cardiovascular epidemic requires awareness of the economic development in the past decades. The rapid economic transformations (industrialization, marketization, urbanization, globalization, and informationalization) contributed to the aging demography, unhealthy lifestyles, and environmental changes. The latter have predisposed to increasing cardiovascular risk factors and the CVD pandemic. Rising CVD rates have had a major economic impact, which has challenged the healthcare system and the whole society. With recognition of the importance of health, initial political steps and national actions have been taken to address the CVD epidemic. Looking to the future, we recommend that 4 priorities should be taken: pursue multisectorial government and nongovernment strategies targeting the underlying causes of CVD (the whole-of-government and whole-of-society policy); give priority to prevention; reform the healthcare system to fit the nature of noncommunicable diseases; and conduct research for evidence-based, low-cost, simple, sustainable, and scalable interventions. By pursuing the 4 priorities, the pandemic of CVD and other major noncommunicable diseases in China will be reversed and the global sustainable development goal achieved.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  China; cardiovascular diseases; prevention & control; risk factors; socioeconomic factors

Mesh:

Year:  2016        PMID: 27297347      PMCID: PMC4910645          DOI: 10.1161/CIRCULATIONAHA.115.008728

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  101 in total

1.  Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China.

Authors:  Shenshen Li; Yangfeng Wu; Xin Du; Xian Li; Anushka Patel; Eric D Peterson; Fiona Turnbull; Serigne Lo; Laurent Billot; Tracey Laba; Runlin Gao
Journal:  Am Heart J       Date:  2014-12-18       Impact factor: 4.749

2.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

3.  Overweight and obesity in China.

Authors:  Yangfeng Wu
Journal:  BMJ       Date:  2006-08-19

4.  Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives?

Authors:  Cheng Huang; Hai Yu; Jeffrey P Koplan
Journal:  Lancet       Date:  2014-08-30       Impact factor: 79.321

5.  Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality.

Authors:  Wuxiang Xie; Gang Li; Dong Zhao; Xueqin Xie; Zaihua Wei; Wei Wang; Miao Wang; Guoxing Li; Wanru Liu; Jiayi Sun; Zhangrong Jia; Qian Zhang; Jing Liu
Journal:  Heart       Date:  2014-10-23       Impact factor: 5.994

6.  The contribution of urinary cations to the blood pressure differences associated with migration.

Authors:  M J Klag; J He; J Coresh; P K Whelton; J Y Chen; J P Mo; M C Qian; P S Mo; G Q He
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

7.  Relationship between salt excretion and blood pressure in various regions of China.

Authors:  L S Liu; S C Tao; S H Lai
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

Review 9.  Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review.

Authors:  Andrew Dunbar; William Gotsis; William Frishman
Journal:  Cardiol Rev       Date:  2013 Mar-Apr       Impact factor: 2.644

10.  Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes.

Authors:  R Gao; A Patel; W Gao; D Hu; D Huang; L Kong; W Qi; Y Wu; Y Yang; P Harris; C Algert; P Groenestein; F Turnbull
Journal:  Heart       Date:  2007-10-11       Impact factor: 5.994

View more
  40 in total

Review 1.  Advance for Cardiovascular Health in China.

Authors:  Yihua Bei; Chao Shi; Zhongrong Zhang; Junjie Xiao
Journal:  J Cardiovasc Transl Res       Date:  2018-12-07       Impact factor: 4.132

2.  The 20 Most Important and Most Preventable Health Problems of China: A Delphi Consultation of Chinese Experts.

Authors:  Yangfeng Wu; Aoming Jin; Gaoqiang Xie; Lei Wang; Kaitai Liu; Guang Jia; Xiaofeng Liang; Jianguo Xu
Journal:  Am J Public Health       Date:  2018-10-25       Impact factor: 9.308

3.  High and Economical Nattokinase Production with Acetoin as a Useful Byproduct from Soybean Milk and Glucose.

Authors:  Zijun Xiao; Jie Shen; Yang Li; Zhuo Wang; Yanshuang Zhao; Yong Chen; Jing-Yi Zhao
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-13       Impact factor: 5.265

Review 4.  The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China.

Authors:  Jun Yang; José G Siri; Justin V Remais; Qu Cheng; Han Zhang; Karen K Y Chan; Zhe Sun; Yuanyuan Zhao; Na Cong; Xueyan Li; Wei Zhang; Yuqi Bai; Jun Bi; Wenjia Cai; Emily Y Y Chan; Wanqing Chen; Weicheng Fan; Hua Fu; Jianqing He; Hong Huang; John S Ji; Peng Jia; Xiaopeng Jiang; Mei-Po Kwan; Tianhong Li; Xiguang Li; Song Liang; Xiaofeng Liang; Lu Liang; Qiyong Liu; Yongmei Lu; Yong Luo; Xiulian Ma; Bernhard Schwartländer; Zhiyong Shen; Peijun Shi; Jing Su; Tinghai Wu; Changhong Yang; Yongyuan Yin; Qiang Zhang; Yinping Zhang; Yong Zhang; Bing Xu; Peng Gong
Journal:  Lancet       Date:  2018-04-17       Impact factor: 79.321

5.  Prevalence of and Trends in the Co-Existence of Obesogenic Behaviors in Adolescents From 15 Countries.

Authors:  Hui Fan; Xingyu Zhang
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

6.  Dietary Cholesterol in the Elderly Chinese Population: An Analysis of CNHS 2010-2012.

Authors:  Shao-Jie Pang; Shan-Shan Jia; Qing-Qing Man; Shuang Song; Yu-Qian Li; Peng-Kun Song; Wen-Hua Zhao; Jian Zhang
Journal:  Nutrients       Date:  2017-08-25       Impact factor: 5.717

7.  Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural China.

Authors:  Kuai Yu; Gaokun Qiu; Ka-Hung Chan; Kin-Bong Hubert Lam; Om P Kurmi; Derrick A Bennett; Canqing Yu; An Pan; Jun Lv; Yu Guo; Zheng Bian; Ling Yang; Yiping Chen; Frank B Hu; Zhengming Chen; Liming Li; Tangchun Wu
Journal:  JAMA       Date:  2018-04-03       Impact factor: 56.272

8.  Randomised trial on effect of involving media reporters in salt reduction programme to increase media reports and the public's knowledge, belief and behaviors on salt and health: Changzhi reporters trial.

Authors:  Zhifang Li; Xiangxian Feng; Tao Wu; Lijing Yan; Paul Elliott; Yangfeng Wu
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

9.  Catastrophic health expenditure in households with chronic disease patients: A pre-post comparison of the New Health Care Reform in Shaanxi Province, China.

Authors:  Yongjian Xu; Jie Ma; Na Wu; Xiaojing Fan; Tao Zhang; Zhongliang Zhou; Jianmin Gao; Jianping Ren; Gang Chen
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

10.  Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014-2018.

Authors:  Lin Mu; Jiamin Liu; Harlan M Krumholz; Xin Zheng; Guohai Zhou; Chaoqun Wu; Bowang Chen; Yuan Lu; Jiapeng Lu; Xiaofang Yan; Zhihong Zhu; Khurram Nasir; Erica S Spatz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.